Nardella, C., Clohessy, J. G., Alimonti, A. & Pandolfi, P. P. Pro-senescence therapy for cancer treatment. Nat. Rev. Cancer 11, 503–511 (2011).
Vassilev, L. T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844–848 (2004).
Kelland, L. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway. Clin. Cancer Res. 13, 4960–4963 (2007).
Alotaibi, M. et al. Radiosensitization by PARP Inhibition in DNA repair proficient and deficient tumor cells: proliferative recovery in senescent cells. Radiat. Res. 185, 229–245 (2016).
CAS PubMed PubMed Central Google Scholar
Milanovic, M. et al. Senescence-associated reprogramming promotes cancer stemness. Nature 553, 96–100 (2018).
Palazzo, A. et al. Transformed cells after senescence give rise to more severe tumor phenotypes than transformed non-senescent cells. Cancer Lett. 546, 215850 (2022).
Wiesmann, N. et al. Zinc Oxide nanoparticles can intervene in radiation-induced senescence and eradicate residual tumor cells. Cancers 13, https://doi.org/10.3390/cancers13122989 (2021).
Ahmadinejad, F. et al. Senolytic-mediated elimination of head and neck tumor cells induced into senescence by Cisplatin. Mol. Pharm. 101, 168–180 (2022).
Gadsden, N. J. et al. Palbociclib renders human papilloma virus-negative head and neck squamous cell carcinoma vulnerable to the senolytic agent navitoclax. Mol. Cancer Res. 19, 862–873 (2021).
PubMed PubMed Central Google Scholar
Ragunathan, K., Upfold, N. L. E. & Oksenych, V. Interaction between fibroblasts and immune cells following DNA damage induced by ionizing radiation. Int. J. Mol. Sci. 21, https://doi.org/10.3390/ijms21228635 (2020).
Barker, H. E., Paget, J. T., Khan, A. A. & Harrington, K. J. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat. Rev. Cancer 15, 409–425 (2015).
CAS PubMed PubMed Central Google Scholar
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243–278 (2023).
Liu, H., Zhao, H. & Sun, Y. Tumor microenvironment and cellular senescence: understanding therapeutic resistance and harnessing strategies. Semin. Cancer Biol. 86, 769–781 (2022).
Li, Q. et al. Chemotherapy-Induced senescence reprogramming promotes nasopharyngeal carcinoma metastasis by circRNA-Mediated PKR Activation. Adv. Sci.10, e2205668 (2023).
Schoetz, U. et al. Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma. Cell Death Dis. 12, 1162 (2021).
CAS PubMed PubMed Central Google Scholar
Liu, Y. et al. Ionizing radiation-induced “zombie” carcinoma-associated fibroblasts with suppressed pro-radioresistance on OSCC cells. Oral. Dis. 29, 563–573 (2023).
D’Ambrosio, M. & Gil, J. Reshaping of the tumor microenvironment by cellular senescence: an opportunity for senotherapies. Dev. Cell 58, 1007–1021 (2023).
Pardella, E. et al. Therapy-induced stromal senescence promoting aggressiveness of prostate and ovarian cancer. Cells 11, https://doi.org/10.3390/cells11244026 (2022).
Ruhland, M. K. et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat. Commun. 7, 11762 (2016).
CAS PubMed PubMed Central Google Scholar
Fane, M. & Weeraratna, A. T. How the ageing microenvironment influences tumour progression. Nat. Rev. Cancer 20, 89–106 (2020).
Chambers, C. R., Ritchie, S., Pereira, B. A. & Timpson, P. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer. Mol. Oncol. 15, 3242–3255 (2021).
PubMed PubMed Central Google Scholar
Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978–990 (2013).
CAS PubMed PubMed Central Google Scholar
Zhu, M. et al. Interleukin-13 promotes cellular senescence through inducing mitochondrial dysfunction in IgG4-related sialadenitis. Int. J. Oral. Sci. 14, 29 (2022).
CAS PubMed PubMed Central Google Scholar
Giannoula, Y., Kroemer, G. & Pietrocola, F. Cellular senescence and the host immune system in aging and age-related disorders. Biomed. J. 46, 100581 (2023).
CAS PubMed PubMed Central Google Scholar
Salminen, A. Feed-forward regulation between cellular senescence and immunosuppression promotes the aging process and age-related diseases. Ageing Res. Rev. 67, 101280 (2021).
Matsuda, S. et al. TGF-beta in the microenvironment induces a physiologically occurring immune-suppressive senescent state. Cell Rep. 42, 112129 (2023).
CAS PubMed PubMed Central Google Scholar
Malaquin, N. & Rodier, F. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP). Methods Cell Biol. 181, 181–195 (2024).
De Martino, M. et al. Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy. Oncoimmunology 9, 1715767 (2020).
PubMed PubMed Central Google Scholar
Wang, Z., Gao, J., Liu, H., Ohno, Y. & Xu, C. Targeting senescent cells and tumor therapy (Review). Int. J. Mol. Med. 46, 1603–1610 (2020).
CAS PubMed PubMed Central Google Scholar
Munoz-Espin, D. & Serrano, M. Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol. 15, 482–496 (2014).
Horton, J. D., Knochelmann, H. M., Day, T. A., Paulos, C. M. & Neskey, D. M. Immune evasion by head and neck cancer: foundations for combination therapy. Trends Cancer 5, 208–232 (2019).
CAS PubMed PubMed Central Google Scholar
Nishimura, J. et al. CDDP-induced desmoplasia-like changes in oral cancer tissues are related to SASP-related factors induced by the senescence of cancer cells. Int. Immunopharmacol. 136, 112377 (2024).
Liu, H. et al. Nasopharyngeal carcinoma: current views on the tumor microenvironment’s impact on drug resistance and clinical outcomes. Mol. Cancer 23, 20 (2024).
PubMed PubMed Central Google Scholar
Khan, C. & Rusan, N. M. Using Drosophila to uncover the role of organismal physiology and the tumor microenvironment in cancer. Trends Cancer https://doi.org/10.1016/j.trecan.2024.01.007 (2024).
Lacas, B. et al. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol. 18, 1221–1237 (2017).
PubMed PubMed Central Google Scholar
Schaue, D. & McBride, W. H. Opportunities and challenges of radiotherapy for treating cancer. Nat. Rev. Clin. Oncol. 12, 527–540 (2015).
PubMed PubMed Central Google Scholar
Chen, Z. et al. Cellular senescence in ionizing radiation (Review). Oncol. Rep. 42, 883–894 (2019).
Tabasso, A. F. S., Jones, D. J. L., Jones, G. D. D. & Macip, S. Radiotherapy-induced senescence and its effects on responses to treatment. Clin. Oncol.31, 283–289 (2019).
Lagadec, C. et al. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res. 12, R13 (2010).
PubMed PubMed Central Google Scholar
Luo, H. et al. Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells. Int. J. Oncol. 43, 1999–2006 (2013).
CAS PubMed PubMed Central Google Scholar
Luo, H. et al. Activation of p53 with Nutlin-3a radiosensitizes lung cancer cells via enhancing radiation-induced premature senescence. Lung Cancer 81, 167–173 (2013).
Comments (0)